Healthcare

The president announced a federal government website that allows Pfizer to sell medicines at low prices to cash-paying consumers.

Chip maker Wolfspeed says it has emerged from Chapter 11 bankruptcy.

Genmab will acquire Merus in an all-cash transaction worth around $8 billion.

Eli Lilly rises after President Donald Trump announces a 100% tariff on drug products from companies not building manufacturing plants in the U.S.

Our annual Healthcare Roundtable sizes up the risks and opportunities as public policy shifts. 16 stocks to buy now.

Companies fall into one of several categories: mental-health-care services, which run clinics or treatment centers; companies that offer digital or virtual care; and pharmaceutical companies.

With talks at an impasse, the administration is floating the idea of permanent job cuts across the federal workforce.

Republicans’ health policies may shift more patients and doctors to concierge practices. Should you join the club?

This year has seen optimism return to the IPO market. with than 150 private companies becoming U.S.-listed through traditional IPO.

Alibaba jumps after unveiling plans to boost investments in artificial intelligence, while Lithium Americas soars on news that the Trump administration is seeking an equity stake in the company.

Kenvue shares claw back some losses after falling to a record low Monday. President Donald Trump made an unproven link between acetaminophen, the active ingredient in Kenvue’s painkiller Tylenol, and autism.

Income is lagging growth this year. But companies like Seagate, Newmont, Tapestry and CVS offer the best of both worlds: solid dividend yields and strong stock performance.

Childhood deaths from preventable diseases have been cut in half over the last century, a trend that is about to reverse. Blame funding cuts from nations such as the U.S., U.K., and France, says the Gates Foundation.

Technical indicators show three biotech stocks poised for further gains.

Nvidia strikes another deal, Miran believes Fed rate is way too high, Disney restores Jimmy Kimmel’s show, and more news to start your day.

Tylenol maker Kenvue ‘strongly disagrees’ there is a causal link between acetaminophen use during pregnancy and autism.

Oracle names new co-CEOs, and Nvidia plans to invest up to $100 billion in OpenAI.

The panel didn’t vote on a significant change to the childhood vaccine schedule because of confusion over the resolution’s language.

As the Fed eases up, it could pay to own a mix of defensive and cyclical stocks, and non-U. S. bonds.

Health Savings Accounts are among the most underused retirement vehicles for young investors. Some financial advisors are working to change that.

The data do continue to suggest it could be an important tool for patients with Type 2 diabetes.

Growing demand for at-home and alternate site medical services are boosting its bottom line.

The U.K.-based firm and other drugmakers are seeking to avoid tariffs on drugs imported into the U.S.

The weight loss drugmaker Novo Nordisk is trying to shore up its obesity pipeline with a potential alternative to its blockbuster Wegovy.

The FDA’s commissioner hasn’t mentioned any other drugmaker or retailer by name in his campaign against prescription drug ads.